Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Praxis Precision Medicines Inc (NQ: PRAX ) 62.49 -2.45 (-3.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Praxis Precision Medicines Inc < Previous 1 2 3 4 Next > Forecasting The Future: 14 Analyst Projections For Praxis Precision Medicine September 04, 2024 Via Benzinga Philip Morris International To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Wednesday September 04, 2024 Via Benzinga Praxis Precision Medicines Touts Encouraging Data For Mid-Stage Epilepsy Drug September 03, 2024 Praxis Precision Medicines reports positive Phase 2 EMBOLD study results for relutrigine in treating SCN2A and SCN8A developmental and epileptic encephalopathy, showing significant seizure reduction... Via Benzinga These Analysts Increase Their Forecasts On Praxis Precision Medicines After Q2 Results August 14, 2024 Via Benzinga PRAX Stock Earnings: Praxis Precision Medicine Beats EPS, Misses Revenue for Q2 2024 August 13, 2024 PRAX stock results show that Praxis Precision Medicine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace What 6 Analyst Ratings Have To Say About Praxis Precision Medicine August 05, 2024 Via Benzinga Demystifying Praxis Precision Medicine: Insights From 7 Analyst Reviews June 18, 2024 Via Benzinga Recap: Praxis Precision Medicine Q4 Earnings March 05, 2024 Via Benzinga Where Praxis Precision Medicine Stands With Analysts October 03, 2023 Via Benzinga Are We Having Fun Yet? Stocks Sell Off On Massive Volume August 03, 2024 In this video, I review the overall market, my game-plan with the indices, how our largest swings are holding up, and the stocks on my radar. Via Talk Markets Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails July 24, 2024 The companies are no longer developing their drug for essential tremor treatment. Via Investor's Business Daily Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday July 09, 2024 Via Benzinga Quarterly & Long-Term Portfolios For The Win July 06, 2024 What a day for Meta! I was planning to add to my position, but the volume was too low. I would have been shaken out of most of it for the swing before it could become this position trade. Via Talk Markets Value Of Praxis Precision Medicines' Lead Program In Essential Tremor Alone Is Underappreciated: Analyst June 24, 2024 Needham rates Praxis Precision Medicines Buy with a $145 target. Key programs include ulixacaltamide for essential tremor (Phase 3 results expected in 2024) and PRAX-628 for focal seizures. Via Benzinga Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure June 20, 2024 The companies are working on treatments for essential tremor, a tricky indication. Via Investor's Business Daily 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 20, 2024 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session May 31, 2024 Via Benzinga Critical Insights From Praxis Precision Medicine Analyst Ratings: What You Need To Know May 16, 2024 Via Benzinga PRAX Stock Earnings: Praxis Precision Medicine Misses EPS, Misses Revenue for Q1 2024 May 13, 2024 PRAX stock results show that Praxis Precision Medicine missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 26, 2024 Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81... Via Benzinga Why Praxis Precision Medicines Stock Is Trading Higher Tuesday March 26, 2024 Praxis Precision Medicines updates Phase 2a study on PRAX-628 in epilepsy patients with photo paroxysmal response, indicating positive response and safety profile, advancing plans for focal epilepsy... Via Benzinga Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday March 26, 2024 U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Praxis, A Top 1% Stock, Soars To Year-High After Epilepsy Treatment Scores Big March 26, 2024 The company said 100% of patients who received the high dose responded to its drug. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 26, 2024 Via Benzinga PRAX Stock Earnings: Praxis Precision Medicine Beats EPS, Beats Revenue for Q4 2023 March 05, 2024 PRAX stock results show that Praxis Precision Medicine beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month January 25, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky." Via Benzinga Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week January 13, 2024 Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will... Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023 September 19, 2023 Via Benzinga Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... Via Benzinga Top 5 Health Care Stocks That May Fall Off A Cliff August 23, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.